Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study.
- 2025-02
- RCT
- Cell reports. Medicine 6(2)
- Yu Song
- Wenjing Ni
- Minghua Zheng
- Huiping Sheng
- Jing Wang
- Shilong Xie
- YongFeng Yang
- Xiaoling Chi
- Jinjun Chen
- Fangping He
- Xiaotang Fan
- Yuqiang Mi
- Jing Zhang
- Bingyuan Wang
- Lang Bai
- Wen Xie
- Bihui Zhong
- Yee Hui Yeo
- Fajuan Rui
- Shufei Zang
- Jie Li
- Junping Shi
- PubMed: 39970876
- DOI: 10.1016/j.xcrm.2025.101939
- High evidence
- Clinical
29.3% of participants in the vitamin E group achieve the primary outcome compared with 14.1% in the placebo group.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 300 mg/day